Grace Therapeutics: 10% owner Opaleye Management Inc. bought 4,256 shares

What happened

• Opaleye Management Inc., reported as a 10% owner, purchased 4,256 shares of Grace Therapeutics at $1.88 per share on Oct 19, 2026, for $8,001. The Form 4, filed Oct 21, 2026, lists the transaction as an open market or private purchase (transaction code P).

Key details

• Transaction date and price: Oct 19, 2026 — 4,256 shares at $1.88 per share (total $8,001); code P (purchase).
• Shares owned after the transaction: not reported in this Form 4.
• Footnotes: F1 states the shares are owned directly by Opaleye, L.P., and Opaleye Management, Inc., as investment manager, may be deemed to beneficially own those securities; F2 states Opaleye Management, Inc. disclaims beneficial ownership except to the extent of its pecuniary interest and that the filing is not an admission of beneficial ownership.
• Filing date: Oct 21, 2026; the filing does not indicate a late report.

Why it may matter

• This filing reports a straight purchase (code P), not an option exercise or a gift.
• Opaleye Management Inc. is reported as a 10% owner, indicating a large holder rather than a company executive.
• A filing does not show why the insider traded or why the company acted.